AU3476599A - Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists) - Google Patents

Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)

Info

Publication number
AU3476599A
AU3476599A AU34765/99A AU3476599A AU3476599A AU 3476599 A AU3476599 A AU 3476599A AU 34765/99 A AU34765/99 A AU 34765/99A AU 3476599 A AU3476599 A AU 3476599A AU 3476599 A AU3476599 A AU 3476599A
Authority
AU
Australia
Prior art keywords
indol
depression
treatment
receptor antagonists
amine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34765/99A
Inventor
Richard Eric Mewshaw
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3476599A publication Critical patent/AU3476599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
AU34765/99A 1998-04-08 1999-04-07 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists) Abandoned AU3476599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5724498A 1998-04-08 1998-04-08
US09057244 1998-04-08
PCT/US1999/007606 WO1999051592A1 (en) 1998-04-08 1999-04-07 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)

Publications (1)

Publication Number Publication Date
AU3476599A true AU3476599A (en) 1999-10-25

Family

ID=22009404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34765/99A Abandoned AU3476599A (en) 1998-04-08 1999-04-07 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)

Country Status (6)

Country Link
EP (1) EP1070063A1 (en)
JP (1) JP2002510682A (en)
CN (1) CN1304409A (en)
AU (1) AU3476599A (en)
CA (1) CA2327360A1 (en)
WO (1) WO1999051592A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221863B1 (en) 1999-01-07 2001-04-24 American Home Products Corp. 3,4-dihydro-2H-benzo[1,4]oxazine derivatives
WO2000040581A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation 3,4-dihydro-2h-benzo[1,4]oxazine derivatives
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
GB0203804D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
US6911445B2 (en) * 2002-09-12 2005-06-28 Wyeth Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058980A (en) * 1962-10-16 Substitution products of benzo-
US4612312A (en) * 1984-07-30 1986-09-16 Merrell Dow Pharmaceuticals Inc. Glutarimide antianxiety and antihypertensive agents
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
DK37790A (en) * 1990-02-13 1991-08-14 Novo Nordisk As INDEX DERIVATIVES, THEIR PREPARATION AND USE
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
NZ305166A (en) * 1995-03-20 1998-12-23 Lilly Co Eli 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments

Also Published As

Publication number Publication date
EP1070063A1 (en) 2001-01-24
CN1304409A (en) 2001-07-18
JP2002510682A (en) 2002-04-09
CA2327360A1 (en) 1999-10-14
WO1999051592A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
IL143979A0 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU5640199A (en) 4-quinolinemethanol derivatives as purine receptor antagonists (i)
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
AU4425399A (en) Novel therapeutic agents that modulate 5-ht receptors
AU2441801A (en) Urotensin-ii receptor antagonists
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
AU3476599A (en) Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU6569898A (en) Leukotriene antagonists useful for treating iritis
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU3386199A (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
AU3260297A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
WO2000007544A3 (en) Vitronectin receptor antagonists
AU6826498A (en) Endotholin receptor antagonists
AU2433400A (en) Use of 5-ht7 receptor antagonists for treating neuronal degeneration resulting from ischemic events
AU2943899A (en) Indole derivatives as 5-ht2a receptor antagonists
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1396400A (en) Process for the preparation of paroxetine hydrochloride

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase